Chinook Therapeutics, Inc. EBITDA Margin 2015-2023 | KDNY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Chinook Therapeutics, Inc. (KDNY) over the last 10 years. The current EBITDA margin for Chinook Therapeutics, Inc. as of June 30, 2023 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2023-06-30 |
$0.01B |
$-0.25B |
-3557.14% |
2023-03-31 |
$0.01B |
$-0.21B |
-3533.33% |
2022-12-31 |
$0.01B |
$-0.18B |
-2571.43% |
2022-09-30 |
$0.06B |
$-0.11B |
-187.72% |
2022-06-30 |
$0.05B |
$-0.08B |
-148.15% |
2022-03-31 |
$0.05B |
$-0.09B |
-161.11% |
2021-12-31 |
$0.05B |
$-0.09B |
-184.31% |
2021-09-30 |
$0.00B |
$-0.14B |
-14100.00% |
2019-09-30 |
$0.02B |
$-0.09B |
-500.00% |
2019-06-30 |
$0.02B |
$-0.09B |
-600.00% |
2019-03-31 |
$0.01B |
$-0.10B |
-738.46% |
2018-12-31 |
$0.02B |
$-0.09B |
-587.50% |
2018-09-30 |
$0.02B |
$-0.10B |
-576.47% |
2018-06-30 |
$0.02B |
$-0.10B |
-566.67% |
2018-03-31 |
$0.02B |
$-0.10B |
-476.19% |
2017-12-31 |
$0.02B |
$-0.10B |
-566.67% |
2017-09-30 |
$0.02B |
$-0.10B |
-550.00% |
2017-06-30 |
$0.02B |
$-0.09B |
-522.22% |
2017-03-31 |
$0.05B |
$-0.07B |
-131.37% |
2016-12-31 |
$0.05B |
$-0.07B |
-133.33% |
2016-09-30 |
$0.08B |
$-0.04B |
-49.38% |
2016-06-30 |
$0.10B |
$-0.02B |
-16.67% |
2016-03-31 |
$0.07B |
$-0.03B |
-43.28% |
2015-12-31 |
$0.07B |
$-0.01B |
-15.07% |
2015-09-30 |
$0.05B |
$-0.02B |
-32.65% |
2015-06-30 |
$0.03B |
$-0.02B |
-68.75% |
2015-03-31 |
$0.02B |
$-0.02B |
-86.96% |
2014-12-31 |
$0.01B |
$-0.02B |
-146.15% |